Ask Your Doctor About

This segment explores the complex, rigorous, and often bizarre process behind naming pharmaceutical drugs. Host Sean Cole interviews Scott Piergiosi of Brand Institute to demystify how thousands of potential names are narrowed down for the market.

This segment explores the creative and strategic processes behind naming pharmaceutical drugs, highlighting the methodologies used by industry leaders like Brand Institute and veteran namer Arlene Tek. It covers how names are derived from linguistic roots, scientific mechanisms of action, and marketing goals to resonate with both patients and medical professionals.

Arlene, a professional name developer, recounts how she coined the name 'Viagra' for a prostate medication, which was later repurposed by Pfizer for their erectile dysfunction drug. The segment also explores the evolution of pharmaceutical branding, from the 'blank canvas' approach of Prozac to the modern landscape of drug naming.

This segment explores the complex process of naming pharmaceutical drugs, highlighting the regulatory influence of the FDA in preventing misleading claims and medication errors. Experts discuss the importance of unique, trademarkable names and the challenges of avoiding lookalike or soundalike confusion between medications.

Experts discuss the visual and phonetic strategies used to create unique, regulatory-approved drug names. The segment explores how letter shapes, sound tonality, and singability influence the branding process for new medications.

The segment explores the creative process behind naming pharmaceutical drugs, focusing on how naming experts like Arlene and Scott Piergesi develop narratives and emotional resonance for products like Toujeo. The discussion highlights the balance between linguistic strategy, marketing, and the personal satisfaction derived from successful branding.